Amedisys, Inc. (AMED)

Amedisys, Inc. (AMED) Healthcare & Pipeline Overview

Amedisys, Inc. is a leading U.S. healthcare provider specializing in home health, hospice, personal care, and high acuity care services. With 19,000 employees, it delivers comprehensive in-home medical and supportive care across 38 states and D.C., focusing on patient recovery, comfort, and preventing hospital readmissions through its extensive network of care centers.

What Is the Investment Thesis for AMED?

Amedisys, Inc. (AMED) presents an investment thesis centered on its strong positioning within the growing U.S. home healthcare market, driven by demographic shifts and a preference for in-home care. The company's diversified service portfolio, encompassing home health, hospice, personal care, and high acuity care, allows it to address a broad spectrum of patient needs and capitalize on the continuum of care. With a market capitalization of $3.32B and a P/E ratio of 30.7, AMED demonstrates established profitability, evidenced by a 6.0% profit margin and a robust 55.4% gross margin. The company's extensive network of 331 home health, 175 hospice, 14 personal-care, and 8 high acuity care centers across 38 states and D.C. as of December 31, 2021, provides a significant operational scale and geographic reach. Key growth catalysts include the aging U.S. population, which increases demand for senior care services, and the ongoing shift towards value-based care models that favor cost-effective in-home solutions. Expansion of its High Acuity Care segment, which brings hospital-level care home, represents a significant future revenue stream and competitive differentiator. Potential risks include regulatory changes in Medicare/Medicaid reimbursement, workforce shortages in skilled healthcare professionals, and intense competition within the fragmented home health and hospice sectors. The company's beta of 0.90 suggests lower volatility compared to the broader market, offering a degree of stability.

Based on FMP financials and quantitative analysis

AMED Key Highlights

• Market Capitalization: $3.32 billion, indicating a significant presence in the healthcare services market.
• Gross Margin: 55.4%, demonstrating strong operational efficiency in service delivery.
• Profit Margin: 6.0%, reflecting the company's ability to convert revenue into net income.
• Extensive Network: Operates 331 home health, 175 hospice, 14 personal-care, and 8 high acuity care centers as of December 31, 2021.
• Geographic Reach: Services provided across 38 states and the District of Columbia, showcasing broad national coverage.

Who Are AMED's Competitors?

AMED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMED's Key Strengths?

• Broad and diversified service portfolio across home health, hospice, personal care, and high acuity care.
• Extensive national footprint with 528 care centers in 38 states and D.C. as of December 31, 2021.
• Strong gross margin of 55.4% indicates efficient service delivery.
• Established brand and operational history since 1982.
• Specialized High Acuity Care segment offers a unique competitive advantage.

What Are AMED's Weaknesses?

• Reliance on government reimbursement programs (Medicare/Medicaid) for a significant portion of revenue.
• Potential for workforce shortages in skilled nurses and therapists, impacting service capacity.
• Relatively low profit margin of 6.0% compared to gross margin, indicating significant operating expenses.
• No dividend yield, which may deter income-focused investors.

What Could Drive AMED Stock Higher?

• Increasing demand for home-based care services driven by the aging U.S. population and preference for care outside traditional institutional settings.
• Further expansion and adoption of the High Acuity Care segment, bringing hospital-level services to more patients' homes, potentially boosting revenue streams over the next 1-3 years.
• Strategic initiatives aimed at improving operational efficiencies and patient outcomes across its 528 care centers, which could enhance profitability.
• Potential for strategic acquisitions in fragmented markets to expand geographic reach and service offerings, consolidating market share.
• Continued integration of advanced technologies like telehealth and remote monitoring to enhance service delivery and patient engagement.

What Are the Key Risks for AMED?

• Rich valuation — a P/E of 30.7 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
• Insider selling — insiders were net sellers of roughly $10.0M recently.
• Regulatory changes in Medicare and Medicaid reimbursement policies, which could impact revenue and profitability for its home health and hospice segments.
• Shortages of skilled healthcare professionals (nurses, therapists), which could limit service capacity and increase labor costs for its 19,000 employees.
• Intense competition within the fragmented home health and hospice markets, potentially leading to pricing pressures or loss of market share.
• Economic downturns or changes in healthcare spending that could reduce demand for services or impact government funding.
• Compliance risks associated with complex healthcare regulations and potential for audits or penalties.

What Are the Growth Opportunities for AMED?

• Expansion of High Acuity Care Services: Amedisys's High Acuity Care segment, which delivers hospital-level and skilled nursing facility care in the home, represents a significant growth avenue. This model addresses the increasing demand for high-quality, cost-effective alternatives to inpatient care, particularly for complex medical conditions. The market for "hospital-at-home" services is projected to grow substantially, driven by patient preference, technological advancements, and payer support for value-based care. By expanding the reach and capacity of its 8 existing centers (as of December 31, 2021), Amedisys can capture a larger share of this nascent but rapidly expanding market, potentially over the next 3-5 years, leveraging its existing infrastructure and clinical expertise.
• Demographic Tailwinds in Home Health and Hospice: The aging U.S. population is a fundamental driver for Amedisys's core Home Health and Hospice segments. With a growing number of individuals aged 65 and older, the demand for post-acute care, chronic disease management, and end-of-life services delivered in the home is steadily increasing. This demographic trend provides a sustained, long-term growth opportunity for Amedisys, ensuring a consistent patient base for its 331 home health and 175 hospice centers (as of December 31, 2021). The market for senior care services is projected to expand significantly over the next decade, offering a stable growth environment.
• Strategic Acquisitions and Geographic Expansion: Amedisys has a history of growth through strategic acquisitions, allowing it to expand its geographic footprint and service offerings. Given the fragmented nature of the home health and hospice markets, there remain numerous opportunities for inorganic growth. By acquiring smaller, regional providers, Amedisys can enhance its presence in underserved markets, consolidate its position, and achieve economies of scale. This strategy can lead to increased market share and operational efficiencies, particularly in states where its current presence is less dense than its 38-state coverage, over a 2-5 year horizon.
• Integration of Technology and Telehealth: The adoption of telehealth and remote patient monitoring technologies can significantly enhance the efficiency and reach of Amedisys's services. Integrating these technologies into its Home Health and High Acuity Care segments can improve patient outcomes, reduce costs, and allow for more proactive management of chronic conditions. This not only improves the quality of care but also expands the capacity of its existing workforce. The telehealth market is experiencing rapid growth, and Amedisys can leverage these tools to differentiate its offerings and serve a broader patient population more effectively over the next 1-3 years.
• Value-Based Care Model Participation: The shift from fee-for-service to value-based care models by government payers and private insurers presents a significant opportunity. Amedisys, with its focus on preventing hospital readmissions and improving patient outcomes in the home, is well-positioned to thrive under these models. By demonstrating superior clinical results and cost efficiencies, the company can secure preferred provider status and participate in innovative payment arrangements that reward quality over volume. This alignment with payer objectives can drive increased referrals and revenue growth, particularly as these models become more prevalent over the next 3-7 years.

What Opportunities Does AMED Have?

• Growing demand for in-home healthcare services driven by an aging population and preference for home-based care.
• Expansion of the High Acuity Care segment into new markets.
• Potential for strategic acquisitions to consolidate market share in a fragmented industry.
• Leveraging technology (telehealth, remote monitoring) to enhance efficiency and reach.
• Increased participation in value-based care models that reward quality and cost-effectiveness.

What Threats Does AMED Face?

• Changes in government healthcare policies and reimbursement rates for home health and hospice.
• Intense competition from other national and regional home healthcare providers.
• Rising labor costs and difficulty in recruiting and retaining skilled healthcare professionals.
• Economic downturns impacting patient ability to pay or government funding.
• Regulatory scrutiny and compliance risks inherent in the healthcare sector.

What Are AMED's Competitive Advantages?

• Extensive Geographic Footprint: Operates a large network of 528 care centers across 38 states and D.C., creating significant scale and market penetration.
• Diversified Service Portfolio: Offers a comprehensive continuum of care (home health, hospice, personal care, high acuity care), allowing for integrated patient management and cross-selling opportunities.
• Clinical Expertise and Reputation: Long-standing presence since 1982 and focus on quality outcomes build trust with patients, families, and referring physicians.
• Regulatory Compliance and Operational Complexity: Navigating the complex regulatory environment for home health and hospice services creates barriers to entry for new competitors.
• High Acuity Care Offering: Its specialized High Acuity Care segment provides a differentiated service that few competitors can replicate easily, offering hospital-level care at home.

What Does AMED Do?

Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana, establishing itself as a prominent provider of healthcare services across the United States. Over decades, the company has evolved to offer a comprehensive suite of in-home care solutions, addressing a wide spectrum of patient needs from recovery and rehabilitation to end-of-life support. Amedisys operates through four primary segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment is foundational, providing skilled nursing, rehabilitation therapies (physical, speech, occupational), social work, and aide services directly in patients' homes. These services are crucial for individuals recovering from surgery, managing chronic disabilities, or dealing with terminal illnesses, with a significant focus on preventing avoidable hospital readmissions. This segment leverages a team of specialized professionals to ensure continuity of care and improved patient outcomes in a comfortable home environment. The Hospice segment is dedicated to offering comfort and support for patients facing terminal illnesses such as cancer, heart disease, pulmonary disease, or Alzheimer's. This includes pain management, emotional and spiritual support, and assistance for families, emphasizing dignity and quality of life during a critical period. The Personal Care segment addresses the daily living needs of patients, providing assistance with activities that enable individuals to maintain independence and well-being at home. This support is vital for many individuals who require non-medical aid to manage their daily routines. The High Acuity Care segment represents an advanced offering, delivering essential elements of inpatient hospital and skilled nursing facility care directly to patients in their homes, alongside palliative care. This innovative approach aims to de-hospitalize care for suitable patients, offering a more personalized and potentially less costly alternative to traditional institutional settings. As of December 31, 2021, Amedisys's operational footprint was substantial, encompassing 331 home health care centers, 175 hospice care centers, 14 personal-care centers, and 8 high acuity care centers. This extensive network spans 38 states and the District of Columbia, underscoring the company's broad geographic reach and commitment to delivering integrated, patient-centered care across diverse regions of the U.S. The company's strategy focuses on expanding access to high-quality, cost-effective care in the home, aligning with broader healthcare trends favoring decentralized and personalized service delivery.

What Products and Services Does AMED Offer?

• Provides home health services for patient recovery from surgery, chronic illness, or terminal conditions.
• Offers skilled nursing, physical, speech, and occupational therapy in patients' homes.
• Delivers hospice care for comfort and support to individuals with terminal illnesses like cancer or heart disease.
• Assists patients with activities of daily living through personal care services.
• Provides high acuity care, bringing essential elements of hospital and skilled nursing facility care to patients' homes.
• Operates a network of 331 home health, 175 hospice, 14 personal-care, and 8 high acuity care centers.
• Focuses on preventing avoidable hospital readmissions through its comprehensive home health programs.
• Serves patients across 38 states and the District of Columbia in the United States.

How Does AMED Make Money?

• Generates revenue primarily through providing skilled nursing, therapy, and supportive care services in patients' homes.
• Receives reimbursement from Medicare, Medicaid, and private insurance payers for its home health, hospice, personal care, and high acuity care services.
• Operates a distributed network of care centers, leveraging local teams of healthcare professionals.
• Focuses on delivering integrated care across multiple segments to address a continuum of patient needs.
• Aims to improve patient outcomes and reduce healthcare costs by providing care in lower-cost home settings.

What Industry Does AMED Operate In?

Amedisys, Inc. operates within the dynamic and growing U.S. healthcare services industry, specifically focusing on medical care facilities that extend into the home. The broader industry is experiencing significant tailwinds driven by an aging population, increasing prevalence of chronic diseases, and a societal shift towards receiving care in less institutionalized, more comfortable home settings. This trend is further supported by technological advancements enabling remote monitoring and telehealth, alongside policy initiatives promoting value-based care and reducing hospital readmissions. Amedisys is positioned as a key player in this evolving landscape, offering a comprehensive continuum of care from post-acute recovery to end-of-life support. The competitive landscape is characterized by both large national providers and numerous smaller, regional operators. Key competitors include LHC Group, Inc. (LHCG), which also offers a range of home health and hospice services. Amedisys differentiates itself through its integrated service model, including its High Acuity Care segment, which brings hospital-level services into the home, addressing a critical and growing need for complex care outside traditional facilities. The market for home health and hospice services is expected to continue its expansion, driven by both demographic factors and cost-efficiency considerations compared to inpatient care.

Who Are AMED's Key Customers?

• Individuals recovering from surgery or acute medical events.
• Patients managing chronic disabilities or long-term illnesses.
• Individuals with terminal illnesses seeking comfort and end-of-life support.
• Elderly individuals requiring assistance with daily living activities.
• Patients who qualify for hospital-level care but prefer to receive it in their homes.

Amedisys, Inc. Financial Trajectory

Amedisys, Inc. (AMED) reported $621.9M in revenue for Q2 2025, reflecting 4.6% growth compared to the prior quarter. The company recorded net income of $67.6M, with diluted EPS of $2.06. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, AMED averaged $1.13 in diluted EPS.

Company Profile

Amedisys, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Baton Rouge, US. The company is led by CEO Richard M. Ashworth. AMED has traded publicly since 1994.

How Amedisys, Inc. Is Valued

Amedisys, Inc. carries a market capitalization of $3.32B, placing it in the mid-cap category. Relative to its peer group, AMED's quantitative score of 50/100 is roughly in line with the peer average of 59/100.

ROE 9%Key Financial Metrics

Return on equity for Amedisys, Inc. stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.9%, showing how much profit it generates from its asset base. AMED trades at a trailing price-to-earnings ratio of 30.65, above the Healthcare sector average of ~23x. Its free cash flow yield is 3.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

Amedisys, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.06 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Amedisys, Inc. revenue of about $2.58B for fiscal 2026, with EPS near $5.17. The estimate reflects 8 contributing analysts.

Net sellingInsider Activity

The most recent 12 insider filings for Amedisys, Inc. break down as 11 sales and 1 purchases. On net that is roughly 560K shares disposed (about $10.0M), a signal worth weighing alongside the fundamentals.

AMED Financials

AMED Latest News

AMED Analyst Consensus

AMED MoonshotScore

What Investors Ask About Amedisys, Inc. (AMED) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources